Laurent Désaubry

4.6k total citations · 1 hit paper
90 papers, 3.2k citations indexed

About

Laurent Désaubry is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Laurent Désaubry has authored 90 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 30 papers in Organic Chemistry and 16 papers in Oncology. Recurrent topics in Laurent Désaubry's work include PI3K/AKT/mTOR signaling in cancer (7 papers), Chemical Synthesis and Analysis (7 papers) and Chemotherapy-induced cardiotoxicity and mitigation (7 papers). Laurent Désaubry is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (7 papers), Chemical Synthesis and Analysis (7 papers) and Chemotherapy-induced cardiotoxicity and mitigation (7 papers). Laurent Désaubry collaborates with scholars based in France, China and United States. Laurent Désaubry's co-authors include Canan G. Nebigil, Nigel Ribeiro, Frédéric Thuaud, Hussein Abou‐Hamdan, Roger A. Johnson, Christine Basmadjian, Dong Wang, Ilana Shoshani, Mingliang Tang and Zhiyin Song and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Laurent Désaubry

87 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis

2019 301 citations Hussein Abou‐Hamdan, Laurent Désaubry et al. profile →

Peers

Countries citing papers authored by Laurent Désaubry

Since Specialization

Citations

This map shows the geographic impact of Laurent Désaubry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Désaubry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Désaubry more than expected).

Fields of papers citing papers by Laurent Désaubry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Désaubry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Désaubry. The network helps show where Laurent Désaubry may publish in the future.

Co-authorship network of co-authors of Laurent Désaubry

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Désaubry. A scholar is included among the top collaborators of Laurent Désaubry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Désaubry. Laurent Désaubry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of capsaicin-derived prohibitin ligands to modulate the Aurora kinase A/PHB2 interaction and mitophagy in cancer cells 2026 ·Communications Biology ·(unknown), (unknown), Deborah Giordano, (unknown), (unknown), Angelo Facchiano, Laurent Désaubry, Giulia Bertolin	0
2	Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies 2023 ·Cells ·Ahmad Najem, Mohammad Krayem, (unknown), (unknown), Fabrice Journé, Ahmad Awada, Laurent Désaubry, Ghanem E. Ghanem	5
3	eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma 2023 ·International Journal of Molecular Sciences ·Sara Steinmann, (unknown), (unknown), Antonio Cigliano, Giovanni Mario Pes, Maria M. Simile, Laurent Désaubry, José J.G. Marı́n, (unknown), Diego F. Calvisi	4
4	Non-classical ferroptosis inhibition by a small molecule targeting PHB2 2022 ·Nature Communications ·Wei Yang, Bo Mu, Jing You, Chenyu Tian, (unknown), Zhiqiang Xu, (unknown), (unknown), Ming Wu, Guo Zhang, Chong Huang, Linli Li, Zhenhua Shao, Lunzhi Dai, Laurent Désaubry, Shengyong Yang	41
5	Development of fluorizoline analogues as prohibitin ligands that modulate C-RAF signaling, p21 expression and melanogenesis 2022 ·European Journal of Medicinal Chemistry ·(unknown), Hussein Abou‐Hamdan, Hajime Yurugi, (unknown), (unknown), Ahmad Najem, Ghanem E. Ghanem, Susumu Nakata, Krishnaraj Rajalingam, Peng Yu, Dong Wang, Canan G. Nebigil, Laurent Désaubry	3
6	Updates on Anticancer Therapy-Mediated Vascular Toxicity and New Horizons in Therapeutic Strategies 2021 ·Frontiers in Cardiovascular Medicine ·(unknown), (unknown), Nadia Benkirane-Jessel, Laurent Désaubry, Canan G. Nebigil	28
7	The Synthetic Small Molecule FL3 Combats Intestinal Tumorigenesis via Axin1-Mediated Inhibition of Wnt/β-Catenin Signaling 2020 ·Cancer Research ·Dakota N. Jackson, (unknown), (unknown), (unknown), Kevin Turner, Xuan Wang, K. Venuprasad, Rhonda F. Souza, Laurent Désaubry, Arianne L. Theiss	20
8	Prokineticin signaling in heart-brain developmental axis: Therapeutic options for heart and brain injuries 2020 ·Pharmacological Research ·Laurent Désaubry, Anumantha G. Kanthasamy, Canan G. Nebigil	14
9	Flavagline synthetic derivative induces senescence in glioblastoma cancer cells without being toxic to healthy astrocytes 2020 ·Scientific Reports ·(unknown), Joseph Seitlinger, (unknown), Geneviève Ubeaud-Séquier, (unknown), (unknown), Laurent Désaubry, Stéphanie Grandemange, Thierry Massfelder, Guy Fuhrmann, Florence Fioretti, Monique Dontenwill, Nadia Benkirane-Jessel, Ysia Idoux‐Gillet	10
10	Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effects 2019 ·Journal of Experimental & Clinical Cancer Research ·(unknown), (unknown), Barbara Petit, (unknown), (unknown), Laurent Désaubry, Armand de Gramont, Éric Raymond, (unknown), Julie Abraham, Marie‐Odile Jauberteau, Danielle Troutaud	19
11	Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer 2018 ·Clinical Cancer Research ·(unknown), Nicolas Martin, (unknown), Catherine Gaudin, Frédéric Commo, (unknown), Nader Al Nakouzi, Ladan Fazli, Elaine Del Nery, Jacques Camonis, Franck Perez, Stéphanie Lerondel, Alain Le Pape, Daniel Compagno, Martin Gleave, (unknown), Laurent Désaubry, Stéphan Vagner, Karim Fizazi, Anne Chauchereau	15
12	The mTOR-S6 kinase pathway promotes stress granule assembly 2018 ·Cell Death and Differentiation ·Aristeidis Sfakianos, (unknown), (unknown), Paraskevi Kritsiligkou, (unknown), Hussein Abou‐Hamdan, Laurent Désaubry, Gino Poulin, Mark Ashe, Alan J. Whitmarsh	75
13	Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cells 2018 ·European Journal of Medicinal Chemistry ·(unknown), Mohammad Krayem, Ahmad Najem, (unknown), Thierry Cresteil, Canan G. Nebigil, Dong Wang, Peng Yu, Embarek Bentouhami, Ghanem E. Ghanem, Laurent Désaubry	31
14	CUG initiation and frameshifting enable production of dipeptide repeat proteins from ALS/FTD C9ORF72 transcripts 2018 ·Nature Communications ·Ricardos Tabet, Laure Schaeffer, Fernande Freyermuth, Mélanie Jambeau, Michael J. Workman, (unknown), (unknown), Jie Jiang, Karen Jansen‐West, Hussein Abou‐Hamdan, Laurent Désaubry, Tania F. Gendron, Leonard Petrucelli, Franck Martin, Clotilde Lagier‐Tourenne	100
15	Molecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment 2016 ·Clinical Cancer Research ·Hélène Malka-Mahieu, Michelle Newman, Laurent Désaubry, Caroline Robert, Stéphan Vagner	66
16	Novel carbocationic rearrangements of 1-styrylpropargyl alcohols 2015 ·Beilstein Journal of Organic Chemistry ·Christine Basmadjian, (unknown), Laurent Désaubry	1
17	Benzofuran derivatives as a novel class of inhibitors of mTOR signaling 2014 ·European Journal of Medicinal Chemistry ·Christophe Salomé, (unknown), Nigel Ribeiro, Frédéric Thuaud, Maria Serova, Armand de Gramont, Sandrine Faivre, Éric Raymond, Laurent Désaubry	31
18	Flavaglines Alleviate Doxorubicin Cardiotoxicity: Implication of Hsp27 2011 ·PLoS ONE ·(unknown), Nigel Ribeiro, Frédéric Thuaud, Gülen Türkeri, (unknown), Mounia Boulberdaa, Canan G. Nebigil, Laurent Désaubry	44
19	Synthesis of Nucleoside 3′-Thiophosphates in One Step Procedure 1999 ·Nucleosides and Nucleotides ·(unknown), Laurent Désaubry, Roger A. Johnson	1
20	Regio-controlled radical substitution of 9-substituted purines 1995 ·Tetrahedron Letters ·Laurent Désaubry, Jean‐Jacques Bourguignon	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact